SL George

767 total citations
14 papers, 597 citations indexed

About

SL George is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, SL George has authored 14 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Public Health, Environmental and Occupational Health and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in SL George's work include Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (8 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). SL George is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (8 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). SL George collaborates with scholars based in United States. SL George's co-authors include CA Schiffer, RK Dodge, AM Mauer, CD Bloomfield, R. John Mayer, Andreas Neubauer, Doris H. Wurster‐Hill, ED Ball, RT Silver and FR Davey and has published in prestigious journals such as Blood and Leukemia.

In The Last Decade

SL George

14 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
SL George United States	9	457	264	169	169	89	14	597
CR Bartram Germany	5	401 0.9×	400 1.5×	158 0.9×	140 0.8×	79 0.9×	6	613
CR Bartram Germany	11	453 1.0×	309 1.2×	206 1.2×	148 0.9×	109 1.2×	17	668
Nobuo Oguma Japan	12	333 0.7×	144 0.5×	111 0.7×	125 0.7×	44 0.5×	32	419
L Elia Italy	13	507 1.1×	461 1.7×	216 1.3×	114 0.7×	109 1.2×	29	691
Dominique Mühlematter Switzerland	14	365 0.8×	130 0.5×	212 1.3×	160 0.9×	43 0.5×	25	528
A Raghavachar Germany	13	331 0.7×	231 0.9×	96 0.6×	168 1.0×	90 1.0×	24	605
RT Silver United States	9	344 0.8×	155 0.6×	149 0.9×	281 1.7×	92 1.0×	13	580
A. Broeckaert-Van Orshoven Belgium	11	292 0.6×	137 0.5×	122 0.7×	150 0.9×	45 0.5×	14	435
M C López-Berges Spain	13	606 1.3×	308 1.2×	251 1.5×	169 1.0×	100 1.1×	21	741
Kristiina Heinonen Finland	16	714 1.6×	369 1.4×	364 2.2×	190 1.1×	78 0.9×	30	918

Countries citing papers authored by SL George

Since Specialization

Citations

This map shows the geographic impact of SL George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SL George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SL George more than expected).

Fields of papers citing papers by SL George

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SL George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SL George. The network helps show where SL George may publish in the future.

Co-authorship network of co-authors of SL George

This figure shows the co-authorship network connecting the top 25 collaborators of SL George. A scholar is included among the top collaborators of SL George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SL George. SL George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Baer, Maria R., SL George, Krzysztof Mrózek, et al.. (2011). Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720. Leukemia. 25(5). 800–807. 16 indexed citations

2.

Lee, EJ, et al.. (1998). An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B. Leukemia. 12(2). 139–143. 12 indexed citations

3.

Neubauer, Andreas, RK Dodge, SL George, et al.. (1994). Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood. 83(6). 1603–1611. 149 indexed citations

4.

Neubauer, Andreas, RK Dodge, SL George, et al.. (1994). Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood. 83(6). 1603–1611. 14 indexed citations

5.

Özer, Hatice Gülçin, SL George, CA Schiffer, et al.. (1993). Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583 [see comments]. Blood. 82(10). 2975–2984. 134 indexed citations

6.

Özer, Hatice Gülçin, SL George, CA Schiffer, et al.. (1993). Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583 [see comments]. Blood. 82(10). 2975–2984. 2 indexed citations

7.

Pui, C-H, DL Williams, SC Raimondi, et al.. (1987). Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Blood. 70(1). 247–253. 112 indexed citations

8.

Pui, C-H, DL Williams, SC Raimondi, et al.. (1987). Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Blood. 70(1). 247–253. 7 indexed citations

9.

Dahl, GV, DK Kalwinsky, S B Murphy, et al.. (1982). Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia. Blood. 60(4). 856–863. 48 indexed citations

10.

Dahl, GV, et al.. (1982). Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia. Blood. 60(4). 856–863. 1 indexed citations

11.

Rivera, Gaston K., GV Dahl, Pratt Cb, et al.. (1979). Second cessation of therapy in childhood lymphocytic leukemia. Blood. 53(6). 1114–1120. 23 indexed citations

12.

Dahl, GV, et al.. (1979). Second cessation of therapy in childhood lymphocytic leukemia. Blood. 53(6). 1114–1120. 1 indexed citations

13.

Dow, LW, et al.. (1977). Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia. Blood. 50(4). 671–682. 76 indexed citations

14.

Dow, LW, et al.. (1977). Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia. Blood. 50(4). 671–682. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact